Revenue by Product

Financials in millions SEK. Fiscal year is January - December.

Millions SEK. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2014
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '14 Dec 31, 2014
Oligomer-specific Vaccine and Monoclonal Antibody	30.00K
Oligomer-specific Vaccine and Monoclonal Antibody Growth	-88.89%

Revenue by Geography

Financials in millions SEK. Fiscal year is January - December.

Millions SEK. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2014
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '14 Dec 31, 2014
Sweden	30.00K
Sweden Growth	-88.89%